About Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych
During the past decade, Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Long-Term Outcomes of HIV-Positive Patients
1999-03-01
2006-09-01
Completed
3,669
Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)
1999-03-01
1999-03-01
Completed
120
A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
2000-08-01
Unknown status
Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
2001-02-01
Unknown status
400
Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)
2001-02-01
2003-09-01
Completed
Effects of Two Anti-HIV Drug Regimens on Quality of Life and Health Care Use Among SMART Study Participants
2002-01-01
2008-11-01
Completed
1,224
Effects of Two Anti-HIV Drug Regimens on HIV Transmission Risk Behavior Among SMART Study Participants
2002-01-01
2008-09-01
Completed
883
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych"
#1 collaborator was "AbbVie" with 1 trials as a collaborator and "Celgene" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych
According to Clinical.Site data, the most researched conditions in "Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych" are
"Immune Thrombocytopenic Purpura" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych" in a lesser frequency.
Clinical Trials Intervention Types at Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych
Most popular intervention types in "Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "BMS-986004 1500 mg IV" (1 trials), "BMS-986004 225 mg IV" (1 trials), "BMS-986004 675 mg IV" (1 trials), "BMS-986004 75 mg IV" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych
The vast majority of trials in "Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych" are
2 trials for "All" genders.
Clinical Trials Status at Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych
Currently, there are NaN active trials in "Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".